REGENXBIO Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RGNX Nasdaq 2836 www.regenxbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for REGENXBIO Inc.

Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street. - Jun 20th, 2025 9:27 am
REGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202 - Jun 5th, 2025 5:05 am
REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202 - Jun 2nd, 2025 5:05 am
Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff - May 20th, 2025 5:00 am
Regenxbio Signs Royalty Deal Worth Up to $250 Million With Healthcare Royalty - May 19th, 2025 2:59 pm
REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 Million - May 19th, 2025 2:05 pm
Earnings Miss: REGENXBIO Inc. Missed EPS By 64% And Analysts Are Revising Their Forecasts - May 14th, 2025 7:01 am
FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment - May 14th, 2025 5:13 am
REGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II - May 13th, 2025 5:05 am
Regenxbio Inc (RGNX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and Financial ... - May 13th, 2025 1:09 am
Regenxbio (RGNX) Q1 Earnings and Revenues Lag Estimates - May 12th, 2025 3:25 pm
Regenxbio: Q1 Earnings Snapshot - May 12th, 2025 2:23 pm
REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational Highlights - May 12th, 2025 2:05 pm
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting - May 8th, 2025 5:05 am
REGENXBIO to Participate in Upcoming Investor Conferences - May 6th, 2025 5:05 am
Regenxbio (RGNX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - May 5th, 2025 8:00 am
REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights - Apr 30th, 2025 2:05 pm
Trump’s FDA Sends a Bullish Signal to Biotech - Apr 22nd, 2025 3:30 am
Biotech stocks slide as Marks resignation seen being negative for sector - Apr 1st, 2025 9:50 am
Regenxbio’s DMD gene therapy drives 122.3% biomarker uptick in three-year-old - Mar 20th, 2025 5:53 am